2 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Amorphical Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available Care (BAT), for the Treatment of Moderate to Severe COVID-19 Patients. AMOR 18 Powder & Inhalation, Placebo - Covid19 | Phase 1 / Phase 2 | Completed | Amorphical Ltd. | 66 | 2021-02-09 | 2024-02-28 |
| A Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Patients amorphous calcium carbonate, crystalline calcium supplements - Hypoparathyroidism | Phase 1 / Phase 2 | Completed | Amorphical Ltd. | 10 | 2013-04-01 | 2015-03-31 |
COVID-19 (1) · Hypoparathyroidism (1)
Inhalation (1)
Israel (2)
Einat Dekel, DVM (1) · Sophia Ish-Shalom, MD (1)